MOONLAKE IMMUNOTHERAPEUTICS (MLTX)
KY61559X1045 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to MLTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 74.31. This target is 49.47% above the current price.
MLTX was analyzed by 23 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about MLTX.
In the previous month the buy percentage consensus was at a similar level.
MLTX was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-09-23 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-09-12 | Needham | Reiterate | Buy -> Buy |
| 2024-09-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-08-26 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2024-08-08 | Needham | Maintains | Buy -> Buy |
| 2024-07-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-25 | Oppenheimer | Initiate | Outperform |
| 2024-06-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-10 | Needham | Reiterate | Buy -> Buy |
| 2024-05-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-08 | Needham | Reiterate | Buy -> Buy |
| 2024-05-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-09 | Needham | Reiterate | Buy -> Buy |
| 2024-04-02 | Goldman Sachs | Initiate | Neutral |
| 2024-03-13 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-03-11 | Needham | Reiterate | Buy -> Buy |
| 2024-03-11 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-03-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-01 | Needham | Reiterate | Buy -> Buy |
| 2024-03-01 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-02-15 | Wolfe Research | Initiate | Outperform |
| 2023-12-18 | Stifel | Maintains | Buy -> Buy |
| 2023-12-08 | Citigroup | Initiate | Buy |
| 2023-12-01 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-11-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-16 | Wedbush | Maintains | Outperform -> Outperform |